Showing 521 - 540 results of 637 for search '(( 20 10 decrease ) OR ( 10 ((meet decrease) OR (((nn decrease) OR (mean decrease)))) ))*', query time: 0.16s Refine Results
  1. 521
  2. 522
  3. 523

    Comparison of seed germination and recovery responses of a salt marsh Halophyte halopeplis perfoliata to osmotic and ionic treatments by Rasool S.G.

    Published 2016
    “…In order to partition salinity effects, we studied seed germination and recovery responses of a coastal salt marsh halophyte Halopeplis perfoliata to different isotonic treatments (?S: -0.5, -1.0, - 1.5, -2.0 and -2.5, MPa) of various salts and polythylene glycol (PEG) under two light regimes (12-h light photoperiod and 24-h complete darkness). …”
    Get full text
    Get full text
    Get full text
    Get full text
  4. 524
  5. 525
  6. 526
  7. 527

    In patients with Chronic Heart Failure Which Polypharmacy Pheno-groups are associated with adverse health outcomes? (Polypharmacy Pheno-groups and Heart failure outcomes) by Mohammed Ibn-Mas'ud, Danjuma

    Published 2023
    “…The median (IQR) age-adjusted Charlson Comorbidity Index (CCI) was 21 – 5. A total of 1475 (20%) participants died within the study period. …”
    Get full text
    Get full text
    Get full text
  8. 528
  9. 529
  10. 530

    Comparing Methods for Induction of Insulin Resistance in Mouse 3T3-L1 Cells. by Al-Jaber, Hend

    Published 2024
    “…TNFα reduced cell proliferation by 10-20%, and chronic TNFα treatment significantly decreased mature adipocytes due to its cytotoxicity. …”
    Get full text
    Get full text
  11. 531
  12. 532
  13. 533
  14. 534
  15. 535
  16. 536
  17. 537
  18. 538

    Proliposome tablets manufactured using a slurry-driven lipid-enriched powders: Development, characterization and stability evaluation by Khan I.

    Published 2018
    “…Proliposome powders were prepared via a slurry method using sorbitol or D-mannitol as carbohydrate carriers in 1:10 or 1:15 w/w lipid phase to carrier ratios. Soya phosphatidylcholine (SPC) and cholesterol were employed as a lipid phase and Beclometasone dipropionate (BDP) was incorporated as a model drug. …”
    Get full text
    Get full text
  19. 539
  20. 540